Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
Premier League fans express mixed feelings about their clubs' readiness for the upcoming season, with concerns over offensive recruitment and squad depth.
British meteorologist's remains found in Antarctica after 66 years, providing closure for his family.
Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
Premier League fans express mixed feelings about their clubs' readiness for the upcoming season, with concerns over offensive recruitment and squad depth.
British meteorologist's remains found in Antarctica after 66 years, providing closure for his family.